AgelessRx Offers Telehealth Access to Longevity Treatments, But Regulatory Oversight Varies

Telehealth platform connects patients with providers for prescriptions, but compounded medications lack FDA approval process

Mar. 14, 2026 at 2:23am

Got story updates? Submit your updates here. ›

AgelessRx operates as a telehealth platform that connects patients with licensed healthcare providers to evaluate eligibility for various longevity-focused treatments, including prescription medications, compounded therapies, and diagnostic testing. While the platform partners with FDA-registered compounding pharmacies, the specific formulations are not subject to the same regulatory review as finished FDA-approved drugs. Consumers should understand the distinction between compounded and approved medications, as well as the limited human longevity data supporting many of the treatments discussed.

Why it matters

As consumer interest in preventive healthcare and longevity-focused care grows, telehealth platforms like AgelessRx that offer access to off-label prescriptions and compounded medications are attracting increased scrutiny. Understanding the regulatory framework, clinical evidence, and pricing structure is important for consumers evaluating whether AgelessRx aligns with their health goals and risk tolerance.

The details

According to the company, AgelessRx operates as a telehealth platform that facilitates connections between patients and licensed healthcare providers. Providers independently evaluate patient histories and, when clinically appropriate, may prescribe treatments aimed at supporting healthspan rather than just treating diagnosed diseases. The platform coordinates the intake process, prescription fulfillment through pharmacy partners, and ongoing patient support. However, the medical decisions remain with the independent providers. AgelessRx's treatment catalog spans 45+ options across categories like longevity, weight management, and cognitive function. Many of these treatments, such as metformin, rapamycin, and GLP-1 medications, are manufactured in FDA-registered facilities but prescribed off-label within longevity discussions. The company also offers compounded therapies, including NAD+, semaglutide, and tirzepatide formulations, which are produced by 503A pharmacies. Pricing ranges from $25 per month for metformin to $949 for multi-cancer detection testing, with no insurance coverage accepted.

  • AgelessRx was founded in 2023 and launched its telehealth platform in 2024.
  • This analysis covers the platform's treatment offerings and operational details as of March 2026.

The players

AgelessRx

A telehealth platform that connects patients with licensed healthcare providers to evaluate eligibility for various longevity-focused treatments, including prescription medications, compounded therapies, and diagnostic testing.

US-licensed Healthcare Providers

Independent clinicians who evaluate patient histories and, when clinically appropriate, prescribe treatments through the AgelessRx platform.

FDA-Registered Compounding Pharmacies

The pharmacy partners that AgelessRx states fill prescriptions for compounded therapies, operating under 503A regulations.

Got photos? Submit your photos here. ›

What they’re saying

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, Grocery Employee (Instagram)

The takeaway

Consumers evaluating AgelessRx should carefully consider the regulatory framework, clinical evidence, and pricing structure, as the platform operates in a space with limited human longevity data and compounded medications that do not undergo the same FDA review as finished approved drugs. Understanding the distinctions between these treatment options and traditional healthcare is important before starting any new prescription therapy.